Although elevated macropinocytosis of KRAS mt tumor cells has been repeatedly verified by different laboratories, the levels are largely variable, and there is currently no conclusive answer to the exact extent of macropinocytosis enhancement by mutant KRAS. This evidence concerns the gene KRAS and neoplasm.